SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-22-282853
Filing Date
2022-11-14
Accepted
2022-11-10 19:07:30
Documents
2
Group Members
ENAVATE SCIENCES GP, LLCENAVATE SCIENCES HOLDINGS, LLCENAVATE SCIENCES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D d421219dsc13d.htm SC 13D 89575
2 EX-99.1 d421219dex991.htm EX-99.1 5598
  Complete submission text file 0001193125-22-282853.txt   96878
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Subject) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90878 | Film No.: 221379107
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2884 SAND HILL ROAD SUITE 100 MENLO PARK CA 94025
Business Address 2884 SAND HILL ROAD SUITE 100 MENLO PARK CA 94025 212-909-3022
Commander Aggregator, LP (Filed by) CIK: 0001953093 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D